Cargando…
The effect of metformin on mortality and severity in COVID-19 patients with diabetes mellitus
AIM: COVID-19 has spread globally with heavy impact on most countries and our therapeutic strategies in COVID-19 patients with diabetes are still limited. Recently, some new information was added to this field. We performed this updated meta-analysis to reveal the underlying effect of metformin on C...
Autores principales: | Yang, Wenxing, Sun, Xuehong, Zhang, Jun, Zhang, Kui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295100/ https://www.ncbi.nlm.nih.gov/pubmed/34302912 http://dx.doi.org/10.1016/j.diabres.2021.108977 |
Ejemplares similares
-
Effects of Metformin on the Gut Microbiota in Obesity and Type 2 Diabetes Mellitus
por: Zhang, Qi, et al.
Publicado: (2020) -
Severity of Gastrointestinal Side Effects of Metformin Tablet Compared to Metformin Capsule in Type 2 Diabetes Mellitus Patients
por: Siavash, Mansour, et al.
Publicado: (2017) -
Inpatient Use of Metformin and Acarbose Is Associated with Reduced Mortality of COVID-19 Patients with Type 2 Diabetes Mellitus
por: Li, Willis, et al.
Publicado: (2021) -
Inpatient use of metformin and acarbose is associated with reduced mortality of COVID‐19 patients with type 2 diabetes mellitus
por: Li, Jinghong, et al.
Publicado: (2021) -
Metformin Use in Diabetes Prior to Hospitalization: Effects on Mortality in Covid-19
por: Li, Jinghong, et al.
Publicado: (2020)